Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by Fe2+-citrate|
|Abstract:||Mangiferin, a naturally occurring glucosylxanthone, has been described as having antidiabetic, antiproliferative, immunomodulatory and antioxidant activities. In this study we report for the first time the iron-complexing ability of mangiferin as a primary mechanism for protection of rat liver mitochondria against Fe2+-citrate induced lipid peroxidation. Thiobarbituric acid reactive substances and antimycin A-insensitive oxygen consumption were used as quantitative measures of lipid peroxidation. Mangiferin at 10 mu M induced near-full protection against 50 gm Fe2+-citrate-induced mitochondrial swelling and loss of mitochondrial transmembrane potential (Delta Psi). The IC50 value for mangiferin protection against Fe2+-citrate-induced mitochondrial thiobarbituric acid reactive substance formation (9.02 +/- 1.12 mu M) was around 10 times lower than that for tert-butythydroperoxide mitochondrial induction of thiobarbituric acid reactive substance formation. The xanthone derivative also inhibited the iron citrate induction of mitochondrial antimycin A-insensitive oxygen consumption, stimulated oxygen consumption due to Fe2+ autoxidation and prevented Fe3+ ascorbate reduction. Absorption spectra of mangiferin-Fe2+/Fe3+ complexes also suggest the formation of a transient charge transfer complex between Fe2+ and mangiferin, accelerating Fe2+ oxidation and the formation of a more stable Fe3+-mangiferin complex unable to participate in Fenton-type reaction and lipid peroxidation propagation phase. In conclusion, these results show that in vitro antioxidant activity of mangiferin is related to its iron-chelating properties and not merely due to the scavenging activity of free radicals. These results are of pharmacological relevance since mangiferin and its naturally contained extracts could be potential candidates for chelation therapy in diseases related to abnormal intracellular iron distribution or iron overload. (c) 2005 Elsevier B.V. All rights reserved.|
|Editor:||Elsevier Science Bv|
|Citation:||European Journal Of Pharmacology. Elsevier Science Bv, v. 513, n. 41671, n. 47, n. 55, 2005.|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.